CRITICAL PATH INSTITUTE Trademark

Trademark Overview

On Wednesday, August 6, 2014, a trademark application was filed for CRITICAL PATH INSTITUTE with the United States Patent and Trademark Office. The USPTO has given the CRITICAL PATH INSTITUTE trademark a serial number of 86358894. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Wednesday, August 11, 2021. This trademark is owned by The Critical Path Institute (C-Path). The CRITICAL PATH INSTITUTE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Promoting collaboration between scientists and university institutions to facilitate innovation in the drug development process
critical path institute

General Information

Serial Number86358894
Word MarkCRITICAL PATH INSTITUTE
Filing DateWednesday, August 6, 2014
Status701 - SECTION 8 - ACCEPTED
Status DateWednesday, August 11, 2021
Registration Number4861274
Registration DateTuesday, November 24, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"INSTITUTE"
Goods and ServicesPromoting collaboration between scientists and university institutions to facilitate innovation in the drug development process

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, May 7, 2015
Primary Code035
First Use Anywhere DateFriday, December 3, 2004
First Use In Commerce DateFriday, December 3, 2004

Trademark Owner History

Party NameThe Critical Path Institute (C-Path)
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressTucson, AZ 85718
Party NameThe Critical Path Institute (C-Path)
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTucson, AZ 85718

Trademark Events

Event DateEvent Description
Wednesday, August 11, 2021NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Wednesday, August 11, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, August 11, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 12, 2021TEAS SECTION 8 RECEIVED
Tuesday, November 24, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 24, 2015REGISTERED-SUPPLEMENTAL REGISTER
Monday, October 19, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 15, 2015ASSIGNED TO LIE
Tuesday, September 15, 2015APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, September 10, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 10, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 10, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, May 28, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, May 28, 2015FINAL REFUSAL E-MAILED
Thursday, May 28, 2015FINAL REFUSAL WRITTEN
Thursday, May 7, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 6, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 6, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 25, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 25, 2014NON-FINAL ACTION E-MAILED
Tuesday, November 25, 2014NON-FINAL ACTION WRITTEN
Wednesday, November 19, 2014ASSIGNED TO EXAMINER
Thursday, August 14, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 9, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

institute path critical innovation drug development process facilitate institutions collaboration between scientists university